M&A Deal Summary

Baxter International Acquires Baxa

On August 25, 2011, Baxter International acquired life science company Baxa for 380M USD

Acquisition Highlights
  • This is Baxter International’s 2nd transaction in the Life Science sector.
  • This is Baxter International’s 5th largest (disclosed) transaction.
  • This is Baxter International’s 7th transaction in the United States.
  • This is Baxter International’s 1st transaction in Colorado.

M&A Deal Summary
Date 2011-08-25
Target Baxa
Sector Life Science
Buyer(s) Baxter International
Deal Type Add-on Acquisition
Deal Value 380M USD

Target

Baxa

Englewood, Colorado, United States
Baxa develops pharmacy technology that enhances the efficiency and safety of oral and IV dose preparation and delivery.

Search 201,429 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Baxter International

Deerfield, Illinois, United States
Category Company
Founded 1931
Sector Medical Products
Employees60,000
Revenue 14.8B USD (2023)
DESCRIPTION
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.
Entrance to Baxter International's corporate headquarters in Deerfield, Illinois.

Baxter International develops, manufactures and markets drugs and medical products for people with a variety of medical conditions. Baxter's operations are comprised of the BioScience and Medical Products segments. The BioScience business processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; biosurgery products; and select vaccines. The Medical Products business manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, infusion pumps, and inhalation anesthetics. The business also provides products and services related to pharmacy compounding, drug formulation and packaging technologies. In addition, the Medical Products business provides products and services to treat end-stage renal disease, or irreversible kidney failure. Baxter International was founded in 1931 and is based in Deerfield, Illinois.

DEAL STATS #
Overall 8 of 20
Sector (Life Science) 2 of 4
Type (Add-on Acquisition) 6 of 14
State (Colorado) 1 of 1
Country (United States) 7 of 14
Year (2011) 2 of 2
Size (of disclosed) 5 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-04-18 Prism Pharmaceuticals

King of Prussia, Pennsylvania, United States

​Prism, located in King of Prussia, Pennsylvania, is a leading specialty pharmaceutical company committed to developing and commercializing acute care cardiovascular products. Prism is focused on recognizing unfulfilled opportunities in existing compounds that target acute care cardiovascular needs and comprehensively developing them to achieve their full market potential.

Buy $338M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2012-02-14 Synovis Life Technologies

St Paul, Minnesota, United States

Synovis Life Technologies, Inc., a diversified medical device company based in St. Paul, Minn., develops, manufactures and markets biological and mechanical products used by several surgical specialties to facilitate the repair and reconstruction of soft tissue damaged or destroyed by disease or injury. The company's products include implantable biomaterials for soft tissue repair, devices for microsurgery and surgical tools - all designed to reduce risks and/or facilitate critical surgeries, improve patient outcomes and reduce healthcare costs.

Buy $325M
Mergr

Product

Company

Legal